Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma
暂无分享,去创建一个
L. Eisenlohr | A. Kovatich | P. McCue | H. Maguire | M. Mastrangelo | E. Lattime | C. Monken | Laurence C Eisenlohr | Carol E Laughlin | Claude E Monken | Edmund C Lattime | Carol E. Laughlin | P. Mccue
[1] P. McCue,et al. Phase i study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer. , 2001, The Journal of urology.
[2] S. Mukherjee,et al. Cytokine gene therapy or infusion as treatment for solid human cancer. , 1998, Journal of immunotherapy.
[3] Geoffrey L. Smith,et al. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. , 1997, The Journal of general virology.
[4] B. Acres,et al. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model. , 1997, Cancer gene therapy.
[5] H. Young,et al. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Schlom,et al. Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. , 1996, Human gene therapy.
[7] J. Gralow,et al. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines , 1996 .
[8] F. Nathan,et al. Gene therapy for human cancer: an essay for clinicians. , 1996, Seminars in oncology.
[9] L. Eisenlohr,et al. Intravesical gene therapy: in vivo gene transfer using recombinant vaccinia virus vectors. , 1994, Cancer research.
[10] E. Jaffee,et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Edmonson,et al. Cutaneous reactions to granulocyte-monocyte colony-stimulating factor. , 1992, Archives of dermatology.
[12] D. Pardoll,et al. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. , 1991, Science.
[13] B. Moss,et al. Vaccinia virus: a tool for research and vaccine development , 1991, Science.
[14] P. Greenberg,et al. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein , 1991, The Lancet.
[15] R. Kamen,et al. The human hematopoietic colony-stimulating factors. , 1987, Science.
[16] B. Moss,et al. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes , 1984, Journal of virology.
[17] R. Prehn,et al. Immunity to methylcholanthrene-induced sarcomas. , 1957, Journal of the National Cancer Institute.
[18] H. Maguire,et al. Cellular vaccine therapies for cancer. , 1998, Cancer treatment and research.
[19] K. Foon,et al. Biological and Hormonal Therapies of Cancer , 1998, Cancer Treatment and Research.
[20] J. Palazzo,et al. Immunohistochemical localization of p21(WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues. , 1997, Human pathology.
[21] J. Gralow,et al. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. , 1996, Blood.
[22] R. Zinkernagel,et al. Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. , 1993, Vaccine.
[23] Fulvio Mavilio,et al. Gene therapy , 1993, Nature.
[24] Vaccinia (smallpox) vaccine. Recommendations of the Immunization Practices Advisory Committee (ACIP) , 1991, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[25] F. Fenner. Smallpox and its eradication , 1988 .
[26] B. Moss,et al. Vaccinia VirusExpression Vector: Coexpression of1-Galactosidase Provides Visual Screening ofRecombinant VirusPlaques , 1985 .